港股異動 | 微盟(2013.HK)漲超7% 與百勝軟件達成戰略合作
格隆匯3月11日丨智慧商業服務提供商微盟(2013.HK)現報19.92港元,大漲7.56%,暫成交2億港元,最新總市值453億港元。昨日,微盟與全渠道數字零售解決方案服務商百勝軟件舉行戰略合作發佈會。雙方將圍繞企業在數字化轉型過程中的數據、場景、業務創新等維度,進行深度融合,發揮各自在私域運營、精準營銷、會員管理、中台搭建等方面優勢,為數字化零售企業提供一體化智慧運營解決方案,重塑零售經營新格局。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.